vs

Side-by-side financial comparison of CoreWeave, Inc. (CRWV) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $1.6B, roughly 1.4× CoreWeave, Inc.). Xylem Inc. runs the higher net margin — 8.9% vs -28.7%, a 37.6% gap on every dollar of revenue.

CoreWeave, Inc. is an American artificial intelligence (AI) cloud-computing company based in Livingston, New Jersey. It specializes in providing cloud-based graphics processing unit (GPU) infrastructure to AI developers and enterprises, and also develops its own chip management software.

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

CRWV vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.4× larger
XYL
$2.1B
$1.6B
CRWV
Higher net margin
XYL
XYL
37.6% more per $
XYL
8.9%
-28.7%
CRWV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CRWV
CRWV
XYL
XYL
Revenue
$1.6B
$2.1B
Net Profit
$-451.7M
$189.0M
Gross Margin
67.6%
37.8%
Operating Margin
-5.7%
11.5%
Net Margin
-28.7%
8.9%
Revenue YoY
2.7%
Net Profit YoY
13.2%
EPS (diluted)
$-0.50
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRWV
CRWV
XYL
XYL
Q1 26
$2.1B
Q4 25
$1.6B
$2.4B
Q3 25
$1.4B
$2.3B
Q2 25
$1.2B
$2.3B
Q1 25
$981.6M
$2.1B
Q4 24
$2.3B
Q3 24
$583.9M
$2.1B
Q2 24
$395.4M
$2.2B
Net Profit
CRWV
CRWV
XYL
XYL
Q1 26
$189.0M
Q4 25
$-451.7M
$335.0M
Q3 25
$-110.1M
$227.0M
Q2 25
$-290.5M
$226.0M
Q1 25
$-314.6M
$169.0M
Q4 24
$326.0M
Q3 24
$-359.8M
$217.0M
Q2 24
$-323.0M
$194.0M
Gross Margin
CRWV
CRWV
XYL
XYL
Q1 26
37.8%
Q4 25
67.6%
38.9%
Q3 25
73.0%
38.9%
Q2 25
74.2%
38.8%
Q1 25
73.3%
37.1%
Q4 24
38.0%
Q3 24
75.5%
37.3%
Q2 24
72.5%
37.8%
Operating Margin
CRWV
CRWV
XYL
XYL
Q1 26
11.5%
Q4 25
-5.7%
14.7%
Q3 25
3.8%
14.7%
Q2 25
1.6%
13.3%
Q1 25
-2.8%
11.2%
Q4 24
11.8%
Q3 24
20.1%
13.3%
Q2 24
19.7%
11.7%
Net Margin
CRWV
CRWV
XYL
XYL
Q1 26
8.9%
Q4 25
-28.7%
14.0%
Q3 25
-8.1%
10.0%
Q2 25
-24.0%
9.8%
Q1 25
-32.1%
8.2%
Q4 24
14.5%
Q3 24
-61.6%
10.3%
Q2 24
-81.7%
8.9%
EPS (diluted)
CRWV
CRWV
XYL
XYL
Q1 26
$0.79
Q4 25
$-0.50
$1.37
Q3 25
$-0.22
$0.93
Q2 25
$-0.60
$0.93
Q1 25
$-1.49
$0.69
Q4 24
$1.33
Q3 24
$-1.82
$0.89
Q2 24
$-1.62
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRWV
CRWV
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$3.2B
$808.0M
Total DebtLower is stronger
$21.4B
$1.9B
Stockholders' EquityBook value
$3.3B
$11.0B
Total Assets
$49.3B
$17.0B
Debt / EquityLower = less leverage
6.41×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRWV
CRWV
XYL
XYL
Q1 26
$808.0M
Q4 25
$3.2B
$1.5B
Q3 25
$1.9B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$1.4B
$989.0M
Q2 24
$1.0B
$815.0M
Total Debt
CRWV
CRWV
XYL
XYL
Q1 26
$1.9B
Q4 25
$21.4B
$2.0B
Q3 25
$14.0B
$2.0B
Q2 25
$11.1B
$2.0B
Q1 25
$8.7B
$2.0B
Q4 24
$2.0B
Q3 24
Q2 24
Stockholders' Equity
CRWV
CRWV
XYL
XYL
Q1 26
$11.0B
Q4 25
$3.3B
$11.5B
Q3 25
$3.9B
$11.2B
Q2 25
$2.7B
$11.1B
Q1 25
$1.9B
$10.8B
Q4 24
$10.6B
Q3 24
$-344.0M
$10.6B
Q2 24
$-1.0B
$10.3B
Total Assets
CRWV
CRWV
XYL
XYL
Q1 26
$17.0B
Q4 25
$49.3B
$17.6B
Q3 25
$32.9B
$17.3B
Q2 25
$26.2B
$17.2B
Q1 25
$21.9B
$16.6B
Q4 24
$16.5B
Q3 24
$16.0B
Q2 24
$15.8B
Debt / Equity
CRWV
CRWV
XYL
XYL
Q1 26
0.18×
Q4 25
6.41×
0.17×
Q3 25
3.62×
0.18×
Q2 25
4.16×
0.18×
Q1 25
4.57×
0.19×
Q4 24
0.19×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRWV
CRWV
XYL
XYL
Operating Cash FlowLast quarter
$1.6B
Free Cash FlowOCF − Capex
$-2.5B
FCF MarginFCF / Revenue
-159.1%
Capex IntensityCapex / Revenue
258.3%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRWV
CRWV
XYL
XYL
Q1 26
Q4 25
$1.6B
$543.0M
Q3 25
$1.7B
$360.0M
Q2 25
$-251.3M
$305.0M
Q1 25
$61.2M
$33.0M
Q4 24
$575.0M
Q3 24
$311.0M
Q2 24
$288.0M
Free Cash Flow
CRWV
CRWV
XYL
XYL
Q1 26
Q4 25
$-2.5B
$460.0M
Q3 25
$-699.8M
$281.0M
Q2 25
$-2.7B
$207.0M
Q1 25
$-1.3B
$-38.0M
Q4 24
$475.0M
Q3 24
$237.0M
Q2 24
$215.0M
FCF Margin
CRWV
CRWV
XYL
XYL
Q1 26
Q4 25
-159.1%
19.2%
Q3 25
-51.3%
12.4%
Q2 25
-223.0%
9.0%
Q1 25
-137.1%
-1.8%
Q4 24
21.1%
Q3 24
11.3%
Q2 24
9.9%
Capex Intensity
CRWV
CRWV
XYL
XYL
Q1 26
4.2%
Q4 25
258.3%
3.5%
Q3 25
175.1%
3.5%
Q2 25
202.3%
4.3%
Q1 25
143.4%
3.4%
Q4 24
4.4%
Q3 24
3.5%
Q2 24
3.4%
Cash Conversion
CRWV
CRWV
XYL
XYL
Q1 26
Q4 25
1.62×
Q3 25
1.59×
Q2 25
1.35×
Q1 25
0.20×
Q4 24
1.76×
Q3 24
1.43×
Q2 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRWV
CRWV

US$1.4B92%
Non Us$129.3M8%

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons